Blockade of IFN-γ does not affect the arthritogenicity of T cells generated during the induction of adjuvant arthritis but exacerbates the polyarthritis produced by adoptive transfer of arthritogenic effector cells

Immunology and Cell Biology

Volumn 83, Issue 2, 2005, Pages 189-195

  Brasted, Melissa ^a,b   Spargo, Llewellyn D J ^a   Mayrhofer, Graham ^a,b   Cleland, Leslie G ^a,c  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Adoptive transfer; Arthritis; Autoimmunity; Interferon (IFN) type II; T lymphocyte

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DB1; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFER; CONTROLLED STUDY; DISEASE EXACERBATION; EFFECTOR CELL; FEMALE; GENE DISRUPTION; INFLAMMATION; LYMPHOCYTE MIGRATION; NONHUMAN; PATHOGENESIS; POLYARTHRITIS; RAT; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ARTHRITIS, EXPERIMENTAL; FEMALE; INTERFERON TYPE II; RATS; SYNOVIAL MEMBRANE; T-LYMPHOCYTES; TIME FACTORS;

AGOUTI;

EID: 16344364697     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01313.x     Document Type: Article

References (32)

1. Pearson CM, Wood FD. Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. VII. Pathologic details of the arthritis and spondylitis. Am. J. Pathol. 1963; 42: 73-95.
2. Yoshino S, Schlipkoter E, Kinne R, Hunig T, Emmrich F. Suppression and prevention of adjuvant arthritis in rats by a monoclonal antibody to the alpha/beta T cell receptor. Eur. J. Immunol. 1990; 20: 2805-808.
3. Spargo LD, Cleland LG, Wing SJ, Hawkes JS, Mayrhofer G. Characterization of thoracic duct cells that transfer polyarthritis. Clin. Exp. Immunol. 2001; 126: 560-69.
4. Kohashi O, Pearson CM, Tamaoki N et al. Role of thymus for N-acetyl muramyl-L-alanyl-D-isoglutamine-induced polyarthritis and granuloma formation in euthymic and athymic nude rats or in neonatally thymectomized rats. Infect. Immun. 1981; 31: 758-66.
5. Jacob CO, Holoshitz J, Van der Meide P, Strober S, McDevitt HO. Heterogeneous effects of IFN-gamma in adjuvant arthritis. J. Immunol. 1989; 142: 1500-505.
6. van der Meide PH, Dubbeld M, Vijverberg K, Kos T, Schellekens H. The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J. Gen. Virol 1986; 67: 1059-71.
7. Wiesenberg I, Van der Meide PH, Schellekens H, Alkan S. Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin. Exp. Immunol. 1989; 78: 245-9.
8. Taurog JD, Sandberg GP, Mahowald ML. The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer. Cell. Immunol. 1983; 80: 198-204.
9. Spargo LD, Hawkes JS, Cleland LG, Mayrhofer G. Recruitment of lymphoblasts derived from peripheral and intestinal lymph to synovium and other tissues in normal rats and rats with adjuvant arthritis. J. Immunol. 1996; 157: 5198-207.
10. Waksman BH, Pearson CM, Sharp JT. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen. J. Immunol. 1960; 85: 403-17.
11. Murphy CA, Langrish CL, Chen Y et al. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003; 198: 1951-7.
12. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 1997; 15: 749-95.
13. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum. 1994; 37: 1062-9.
14. Pober JS, Gimbrone MA, Lapierre LA et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 1986; 137: 1893-6.
15. Gerritsen ME, Kelley KA, Ligon G et al. Regulation of the expression of intercellular adhesion molecule 1 in cultured human endothelial cells derived from rheumatoid synovium. Arthritis Rheum. 1993; 36: 593-602.
16. Issekutz TB, Stoltz JM, Van der Meide P. Lymphocyte recruitment in delayed-type hypersensitiviry. The role of IFN-gamma. J. Immunol. 1988; 140: 2989-93.
17. Stanford MM, Issekutz TB. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo. J. Leukoc. Biol. 2003; 74: 791-9.
18. Rosloniec EF, Latham K, Guedez YB. Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmuniry. Arthritis Res. 2002; 4: 333-6.
19. Matthys P, Vermeire K, Heremans H, Billiau A. The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis. J. Leukoc. Biol. 2000; 68: 447-54.
20. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996; 157: 3223-7.
21. Willenborg DO, Fordham SA, Staykova MA, Ramshaw IA, Cowden WB. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J. Immunol. 1999; 163: 5278-86.
22. O'Brien NC, Charlton B, Cowden WB, Willenborg DO. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction. J. Immunol. 1999; 163: 6841-7.
23. Chu CQ, Wittmer S, Dalton DK. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000; 192: 123-8.
24. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J. Immunol. 1997; 158: 5507-13.
25. Manoury-Schwartz B, Chiocchia G, Bessis N et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J. Immunol. 1997; 158: 5501-506.
26. Guedez YB, Whittington KB, Clayton JL et al. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a non-susceptible mouse strain. Arthritis Rheum. 2001; 44: 2413-24.
27. Nakajima H, Takamori H, Hiyama Y, Tsukada W. The effect of treatment with recombinant gamma-interferon on adjuvant-induced arthritis in rats. Agents Actions 1991; 34: 63-5.
28. Boissier MC, Chiocchia G, Bessis N et al. Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur. J. Immunol. 1995; 25: 1184-90.
29. Liew FY. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 1995; 7: 396-9.
30. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 1994; 55: 97-179.
31. Bober LA, Rojas-Triana A, Jackson JV et al. Regulatory effects of interleukin-4 and interleukin-10 on human neutrophil function ex vivo and on neutrophil influx in a rat model of arthritis. Arthritis Rheum. 2000; 43: 2660-67.
32. Sigidin YA, Loukina GV, Skurkovich B, Skurkovich S. Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis. Scand. J. Rheumatol. 2001; 30: 203-207.